Osteoblast IL-33 mRNA expression is regulated by PTH, and IL-33 treatment causes both increased osteoblastic matrix mineralisation and reduced osteoclast formation in vitro
Hanan Saleh(Payame Noor University), Matthew T. Gillespie(Hudson Institute of Medical Research), T. Martin(The University of Melbourne), Jmw Quinn
Cited by 0
Related Papers
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
|Endocrine Reviews|1999|2.3k
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
|Journal of Clinical Investigation|1999|1.7k
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
|Endocrinology|1999|536
Osteotropic Agents Regulate the Expression of Osteoclast Differentiation Factor and Osteoprotegerin in Osteoblastic Stromal Cells
|Endocrinology|1998|452
Activated T Lymphocytes Support Osteoclast Formation in Vitro
|Biochemical and Biophysical Research Communications|1999|425